Defining mild, moderate, and severe fatigue in cancer patients and survivors: E2Z02, a trial of the Eastern Cooperative Oncology Group.
Xin Shelley Wang
No relevant relationships to disclose
Fengmin Zhao
No relevant relationships to disclose
Michael Fisch
No relevant relationships to disclose
Tito R. Mendoza
No relevant relationships to disclose
Ann M. O'Mara
No relevant relationships to disclose
David Cella
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Charles S. Cleeland
No relevant relationships to disclose